Similar articles

• Intramuscular haloperidol decanoate for neuroleptic maintenance therapy.

  arap Mengech HN, Wazome EG. arap Mengech HN, et al. East Afr Med J. 1984 Jun;61(6):435-8. East Afr Med J. 1984. PMID: 6152736 No abstract available.
• Longterm maintenance therapy with depot haloperidol in schizophrenia.

  Zbytovský J. Zbytovský J. Homeost Health Dis. 1991;33(5-6):287. Homeost Health Dis. 1991. PMID: 18265499 No abstract available.
• Neuroleptic levels by radioreceptor assay and clinical response during treatment of acute exacerbation of schizophrenia--some preliminary findings.

  Greenberg JS, Brown WA, Laughren TP, Krantz J. Greenberg JS, et al. Psychopharmacol Bull. 1983;19(1):74-6. Psychopharmacol Bull. 1983. PMID: 6131470 No abstract available.
• Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.

  Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T. Midha KK, et al. J Psychiatry Neurosci. 1994 Jul;19(4):254-64. J Psychiatry Neurosci. 1994. PMID: 7918346 Free PMC article. Review.
• [The "neuroleptic threshold"--a review of the literature].

  Abraham D, Kissling W, Lauter H. Abraham D, et al. Psychiatr Prax. 1996 May;23(3):109-16. Psychiatr Prax. 1996. PMID: 8710999 Review. German.